News
Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...
GILD slides 2.6% after FDA halts trials for HIV candidates, GS-1720 and GS-4182, over safety concerns in patients.
The European Medicines Agency (EMA) has warned that popular weight-loss and diabetes drugs containing semaglutide — including ...
5hon MSN
DEP, the most common plasticiser in softgels, is considered to have relatively low toxicity and is used in small amounts. The ...
Advert Previous studies linked the drug to a rare eye condition known as non-arteritic anterior ischemic optic neuropathy ...
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of ...
EU pushes for India to ease Quality Control Orders in FTA negotiations, but concerns arise over foreign interference.
Diana Moser has, to the best of her knowledge, not contracted Lyme disease, a welcome status quo that might be credited to ...
Czech innovative drug manufacturers say they hope the final version of the 'Pharma Package' will strengthen Europe’s competitiveness and attractiveness for research and innovation.
OneSource Specialty Pharma partners with Swedish biotech company Xbrane, on its biosimilar portfolio
OneSource Specialty Pharma partners with Xbrane Biopharma for biosimilar manufacturing, aiming to strengthen global supply ...
The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib ...
U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results